What should I ask my GP about GLP-1 medicines?
Answer a few questions and get a printable visit sheet for your GP, a specialist or a private prescriber: what to bring, questions for your situation, how to check an online service, and when to call 999 or NHS 111.
Your visit sheet is ready
Tap any line in "About" or any question to change the words. Remove questions with ×, or add your own. Ticks print too.
What this means
What this doesn't mean
- It isn't a yes or a no. No tool can tell whether a GLP-1 medicine suits someone. A prescriber decides that after a history, a check-up and tests.
- It isn't every question. It covers the common ones and those your answers point to. Your GP may ask about things not listed here.
- Don't change any medicine on your own. The dose questions are for the prescriber to answer, not for you to act on before the visit.
Why each question is on your sheet
The rule behind each question for your situation, with its source. The numbers match the sources at the foot of the sheet. All checked 12 Oct 2026.
Read before the visit
How this works
You answer up to 9 short questions. Only the first one is needed. The tool then picks questions from a fixed list, and every question is tied to a source: a UK drug label, MHRA advice, NICE guidance or the pharmacy regulator's rules.2,5,1,6
Eight core questions go on every sheet. Your answers add more. For example, insulin or a sulfonylurea (such as gliclazide) adds a question about low blood sugar, because the Ozempic label warns about low sugar (hypos) with that mix.3
If you add height and weight, the sheet shows BMI against NICE's thresholds, including the lower ones NICE uses for South Asian, Chinese, other Asian, Middle Eastern, Black African and African-Caribbean backgrounds. A waist measurement adds the waist-to-height ratio: 0.5 to 0.59 is increased and 0.6 or more is high.8 These numbers describe weight. They are not a threshold for medicine.
The "Check your provider" box uses the General Pharmaceutical Council's rules for online pharmacies and MHRA advice.6,7,5 The red box lists the symptoms that need 999 or NHS 111, and how to report a side effect on the Yellow Card scheme.12,9
What this can't tell you
- Whether a GLP-1 medicine suits you, or which one. That's for a prescriber who has checked you.
- Anything about your dose. The tool never suggests one.
- Whether your local NHS area offers these medicines yet. The NHS rollout is phased in England and differs in Scotland, Wales and Northern Ireland.1
Questions people ask
Is anything I type saved or sent anywhere?
No. The sheet is built inside your browser. Nothing you type is sent to us or stored, and there is no link that contains your answers. Only if you choose "Email it to me" do we pass the sheet and your address to our email service once, to deliver it.
Can I make a sheet for my mother or father?
Yes. Choose "A family member" on the first screen and the sheet is written about them.
Should I book a GP appointment to ask about Mounjaro on the NHS?
In England the NHS is phasing tirzepatide (Mounjaro) in by groups,1 and some local NHS areas say they will contact people in the current group and ask people not to book GP appointments about it unless invited.13 You can still raise it at a routine review, and the sheet works for any GP, specialist or private prescriber.
Why does it ask about the contraceptive pill?
Tirzepatide (Mounjaro) may make the pill less reliable. The UK label and the MHRA advise switching to a non-pill method, or adding a barrier method such as condoms, for 4 weeks after starting and for 4 weeks after each dose increase.4,5
I'm already taking a GLP-1. Is this useful for me?
Yes. Choose "Already taking one" and the sheet becomes a review: who prescribed it and how they checked you, your dose, whether your pen could be a fake, and whether it's working well enough to continue.6,10,11
How do I report a side effect?
Use the MHRA's Yellow Card scheme, at yellowcard.mhra.gov.uk or in the Yellow Card app. Anyone can report, including patients and carers, and the MHRA asks for reports of suspected fake products too.9,5
Sources
- NICE. Tirzepatide for managing overweight and obesity, TA1026, 23 December 2024: recommendation 1.1 and the phased groups in "What this means in practice". nice.org.uk. Checked 12 Oct 2026.
- Novo Nordisk. Wegovy 2.4 mg FlexTouch summary of product characteristics, UK label (electronic Medicines Compendium), sections 4.1–4.6. medicines.org.uk. Checked 12 Oct 2026.
- Novo Nordisk. Ozempic (semaglutide) US prescribing information, revised May 2026: sections 5, 7, 8.3. PDF. Checked 12 Oct 2026.
- Eli Lilly. Mounjaro KwikPen summary of product characteristics, UK label (electronic Medicines Compendium), updated 8 September 2026: section 4.5 (oral contraceptives). medicines.org.uk. Checked 12 Oct 2026.
- MHRA. GLP-1 medicines for weight loss and diabetes: what you need to know. Updated 5 February 2026. gov.uk. Checked 12 Oct 2026.
- General Pharmaceutical Council. Online pharmacies to strengthen safeguards to prevent unsafe supply of medicines. 4 February 2025. pharmacyregulation.org. Checked 12 Oct 2026.
- General Pharmaceutical Council. Providing weight management services: FAQs (video, in person or GP records to check weight; a phone call or a photo alone is not enough). pharmacyregulation.org. Checked 12 Oct 2026.
- NICE. Overweight and obesity management, NG246 (published 14 January 2025, updated 8 January 2026), recommendations 1.9.10 and 1.9.11, and waist-to-height ratio. nice.org.uk. Checked 12 Oct 2026.
- MHRA. Yellow Card scheme: report a side effect, or a suspected fake medicine. yellowcard.mhra.gov.uk. Checked 12 Oct 2026.
- MHRA Drug Safety Update. Falsified Mounjaro (tirzepatide) KwikPen 15 mg pre-filled pens. 24 February 2026. gov.uk. Checked 12 Oct 2026.
- NICE. Semaglutide for managing overweight and obesity, TA875, recommendation 1.2 (consider stopping if less than 5% of weight is lost after 6 months). nice.org.uk. Checked 12 Oct 2026.
- NHS. When to call 999 (and NHS 111 if you're not sure). Page last reviewed 3 February 2023. nhs.uk. Checked 12 Oct 2026.
- NHS South West London Integrated Care Board. Weight management: tirzepatide ("if you are eligible, you will be contacted directly"). Updated 30 July 2026. southwestlondon.icb.nhs.uk. Checked 12 Oct 2026.
The sheet itself cites up to 30 more sources, listed at its foot. Last checked 12 Oct 2026 · Next review due Jan 2027
How this tool was made. Written by the GLP Guidebook team from the sources above. It's general information, not medical advice. Talk to your GP or another qualified prescriber before starting, stopping or changing any medicine. In an emergency, call 999; if you're not sure, call NHS 111 (in Northern Ireland, your GP surgery's out-of-hours line). How we write